Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Nephrol.

Sec. Clinical Research in Nephrology

Volume 5 - 2025 | doi: 10.3389/fneph.2025.1630867

This article is part of the Research TopicModifiable Risk Factors for Chronic Kidney Disease ProgressionView all 6 articles

The global burden of chronic kidney disease (CKD) attributable to high sodium intake: a comprehensive analysis of trends from 1990 to 2021 and burden prediction to 2040

Provisionally accepted
Yawen  LuYawen Lu1Jianfeng  MaJianfeng Ma1Yang  HuYang Hu1Rumeng  ZhengRumeng Zheng1Liping  LiuLiping Liu1Kaili  LinKaili Lin2Kun  ZhangKun Zhang3Yongfeng  WangYongfeng Wang1*Sheng  LiSheng Li4*
  • 1The First Clinical Medical College of Lanzhou University, lanzhou, China
  • 2The First People's Hospital of Lanzhou, lanzhou, China
  • 3School of Stomatology Lanzhou University, lanzhou, China
  • 4First Hospital of Lanzhou University, Lanzhou, China

The final, formatted version of the article will be published soon.

Chronic kidney disease (CKD) is a progressive condition affecting over 10% of the global population, with high sodium intake identified as a critical modifiable risk factor. This study investigated the global burden of CKD due to excessive sodium intake in 204 countries and territories from 1990 to 2021 and made the first future projections to 2040, addressing gaps in longitudinal analysis of sodium-related CKD trends and demographic differences.Data from the Global Burden of Disease (GBD) 2021 database were analyzed to quantify CKD-related deaths and disability-adjusted life years (DALYs) linked to high sodium intake. Age-standardized mortality rates (ASMR) and DALY rates (ASDR), alongside socio-demographic index (SDI), were used to assess regional and demographic variations. Statistical analyses in R included joinpoint regression to identify temporal inflection points and age-period-cohort (APC) modeling to disentangle age, period, and birth cohort effects. Future projections show that from 2021 to 2040, the global ASMR trend is stabilizing and ASDR is on the rise. And male ASMR and ASDR have been consistently higher than female ASMR. This gender difference is expected to continue for a long time, with men continuing to bear a greater burden of chronic kidney disease than women.Between 1990 and 2021, global CKD deaths attributed to high sodium intake surged 13.7-fold (2,607 to 69,954), while DALYs increased by 135% (741,197 to 1,705,325). ASMR and ASDR rose markedly in high-income regions (20.73% and 6.77%, respectively), with Latin America and the Caribbean reporting the highest burdens (ASMR: 1.49/100,000; ASDR: 33.21/100,000). Males exhibited consistently higher burdens than females, peaking in the 65-79 age group. Low SDI regions showed declining trends, contrasting with widening inequalities in medium SDI areas.The global CKD burden attributable to high sodium intake has escalated dramatically over three decades, driven by aging populations, dietary shifts, and regional disparities. Urgent, targeted interventions-such as sodium reduction policies, gender-specific health strategies, and enhanced healthcare accessare critical to curbing this trend, particularly in high-risk demographics and high-income regions.

Keywords: Chronic Kidney Disease, High sodium intake, Global burden, Joinpoint regression analysis, age-period-cohort model, future projections

Received: 25 May 2025; Accepted: 23 Jul 2025.

Copyright: © 2025 Lu, Ma, Hu, Zheng, Liu, Lin, Zhang, Wang and Li. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Yongfeng Wang, The First Clinical Medical College of Lanzhou University, lanzhou, China
Sheng Li, First Hospital of Lanzhou University, Lanzhou, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.